<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24173188</article-id>
      <article-id pub-id-type="pmc">3798359</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132128</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Chronic graft-versus-host disease: clinical presentation of multiple
lesions of lichenoid and atrophic pattern<sup><xref ref-type="fn" rid="fn03">*</xref></sup></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Doen&#xE7;a enxerto contra hospedeiro cr&#xF4;nica:
apresenta&#xE7;&#xE3;o cl&#xED;nica com in&#xFA;meras les&#xF5;es de
padr&#xE3;o liquen&#xF3;ide e de car&#xE1;ter atr&#xF3;fico</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vasconcelos</surname>
            <given-names>Luiza</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vieira</surname>
            <given-names>&#xC9;rica Cristina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Minicucci</surname>
            <given-names>Eliana Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salvio</surname>
            <given-names>Ana Gabriela</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Souza</surname>
            <given-names>Mair Pedro</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Mariangela Esther Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Silvio Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff06">6</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Residency Program - - Department of Dermatology and Radiotherapy.
Botucatu Medical School, S&#xE3;o Paulo State University J&#xFA;lio de Mesquita
Filho (FMB-UNESP) - Botucatu (SP), Brasil.</aff>
      <aff id="aff02"><label>2</label> DDS, PhD - Stomatologist - Department of Dermatology and Radiotherapy.
Botucatu Medical School, S&#xE3;o Paulo State University J&#xFA;lio de Mesquita
Filho (FMB-UNESP) - Botucatu (SP), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, PhD - Dermatologist - Amaral Carvalho Hospital - Ja&#xFA; (SP) -
Brazil.</aff>
      <aff id="aff04"><label>4</label> MD - Hematologist - Amaral Carvalho Hospital - Ja&#xFA; (SP) -
Brazil.</aff>
      <aff id="aff05"><label>5</label> MD, PhD - Associate Professor - Department of Pathology. Botucatu
Medical School, S&#xE3;o Paulo State University J&#xFA;lio de Mesquita Filho
(FMB-UNESP) - Botucatu (SP), Brazil.</aff>
      <aff id="aff06"><label>6</label> MD, PhD - Full Professor - Department of Dermatology and Radiotherapy.
Botucatu Medical School, S&#xE3;o Paulo State University J&#xFA;lio de Mesquita
Filho (FMB-UNESP) - Botucatu (SP), Brazil.</aff>
      <author-notes>
        <corresp id="c01"> MAILING ADDRESS: Silvio Alencar Marques, Departamento de Dermatologia
e Radioterapia, Faculdade de Medicina de Botucatu, Distrito de Rubi&#xE3;o Junior -
S/N 18618-970 - Botucatu - SP Brazil, E-mail: <email>smarques@fmb.unesp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>5</issue>
      <fpage>799</fpage>
      <lpage>802</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Graft-versus-host disease is observed mainly in recipients of hematopoietic cell
transplantation and is expressed by cutaneous or systemic signals and symptoms.
Graft-versus-host disease is clinically classified as acute or chronic. Chronic
Graft-versus-host disease occurs in up to 70% of hematopoietic cell transplanted
patients and its clinical manifestations have important impact on morbidity and
quality of life. The authors report an expressive cutaneous, oral and adnexal
involvement in a patient with chronic Graft-versus-host disease with multiple lesions
of lichenoid and atrophic pattern.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Doen&#xE7;a enxerto contra hospedeiro &#xE9; observada principalmente em
pacientes transplantados de c&#xE9;lulas de origem hematopoi&#xE9;ticas e se
expressa por sinais e sintomas cut&#xE2;neos ou sist&#xEA;micos. Clinicamente, a
Doen&#xE7;a enxerto contra hospedeiro &#xE9; classificada em aguda ou
cr&#xF4;nica. As do tipo cr&#xF4;nico ocorrem em at&#xE9; 70% dos pacientes e
suas manifesta&#xE7;&#xF5;es t&#xEA;m impacto importante na morbidade e na
qualidade de vida. Os autores relatam caso com extenso comprometimento
cut&#xE2;neo, oral e de anexos cut&#xE2;neos em paciente com Doen&#xE7;a
enxerto contra hospedeiro cr&#xF4;nica expressa por in&#xFA;meras les&#xF5;es
de padr&#xE3;o liquen&#xF3;ide e de atrofia cut&#xE2;nea.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Bone marrow transplantation</kwd>
        <kwd>Clinical evolution</kwd>
        <kwd>Graft vs host disease</kwd>
        <kwd>Lichen sclerosus et atrophicus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>The graft-versus-host disease (GVHD) is an immune-mediated syndrome expressed by
cutaneous or cutaneous / systemic signals and symptoms, mainly in recipients of
allogeneic stem cells or bone marrow transplantation, but also following blood
transfusion and solid organ transplantation.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r03">3</xref></sup> Graft-versushost disease
is induced and maintained by mature donor T cells, which clonally expand in an
antigenspecific manner after the recognition of non-self HLA expressed on the surface of
the host's nucleated cells, thus increasing HLA incompatibility between donor and
recipient.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r03">3</xref></sup> Graft-versus-host disease is clinically classified as
acute or chronic. Acute GVHD (aGVHD) is historically defined as the onset of signs and
symptoms within 100 days of transplant, and chronic GVHD (cGVHD) will appear after that
period.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> However, recent
transplant protocols, with less aggressive conditioning and new immune modulating
strategies have altered the classification; therefore, the aGVHD category includes the
classic aGVHD occurring within 100 days after transplant and the persistent, recurrent
or late aGVHD.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Chronic GVHD includes
the classic cGVHD occurring any time after transplant and an overlap syndrome in which
features of cGVHD and aGVHD appear together.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Chronic GVHD occurs in up to 70% of hematopoietic cell
transplanted patients.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup> Dermatologists and stomatologists must
play an active role in the management and treatment of patients with GVHD, as oral and
cutaneous lesions have severe impact on morbidity and quality of life.</p>
      <p>We report a clinical case of cGVHD with expressive cutaneous, oral and adnexal
involvement occurring despite immunosuppressive therapy, presenting with numerous
lichenoid and atrophic lesions.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 52-year-old male patient presented with a history of an allogeneic bone-marrow
transplant (matched sibling donor) performed in a reference Hospital, due to acute
myeloid leukemia one year before. A conditioning regimen had been followed with oral
busulfan and fludarabine phosphate and he was immunosuppressed from day 2 pre-transplant
with cyclosporine, initial dose of 3mg/kg and 7mg/kg after the 21<sup>th</sup> day
post-transplant, sustained for 241 days plus tacrolimus and mycophenolate mofetil for
seven and 45 days respectively. The patient denied acute GVHD and his clinical follow-up
was unremarkable until six months post-transplant, when oral and skin lesions of chronic
GVHD appeared. Since then the patient has been treated with prednisone up to 1mg/kg/day
with partial remission of the clinical picture. The initial skin lesions were described
as erythematous and pruriginous papules, starting on the trunk with progressive
spreading and oral lesions similar to lichen planus, with ulcers on the lower lip
causing restriction to mouth opening.</p>
      <p>Examination showed diffuse spotted hyper and hypopigmented skin, multiple lichenoid and
atrophic lesions plus almost complete scarring alopecia, acral edema and erythema plus
onychodistrophia of the 20 nails (<xref ref-type="fig" rid="f01">Figures 1</xref>-<xref ref-type="fig" rid="f04">4</xref>). Buccal examination showed shallow ulcers on the
buccal mucosa and tongue, periodontal disease, salivary gland hypofunction, depapillated
tongue and decreased taste. No pulmonary, gastrointestinal or renal involvement was
detected. Histology of skin lesions showed discrete hyperkeratotic and atrophic
epidermis with vacuolar interface dermatitis and scattered apoptosis of keratinocytes
plus superficial sclerosis, vascular proliferation and mild lymphocytic infiltrate,
suggestive of late evolution of lichenoid lesions (<xref ref-type="fig" rid="f05">Figures 5</xref> and <xref ref-type="fig" rid="f06">6</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Graft-versus-host disease: spotted hyper and hypopigmented skin on the face</p>
        </caption>
        <graphic xlink:href="abd-88-05-0799-g01"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Graft-versus-host disease: more evident lichenoid and atrophic lesions on the
back</p>
        </caption>
        <graphic xlink:href="abd-88-05-0799-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Graft-versus-host disease: discrete hyperkeratotic and atrophic epidermis plus
vascular proliferation and mild lymphocytic infiltrate on the papillary dermis</p>
        </caption>
        <graphic xlink:href="abd-88-05-0799-g05"/>
      </fig>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p>Graft-versus-host disease: high-power view shows hyperkeratotic and atrophic
epidermis, vacuolar changes, apoptotic cell, discrete lymphocytic infiltration and
incontinent melanin in the papillary dermis</p>
        </caption>
        <graphic xlink:href="abd-88-05-0799-g06"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Chronic GVHD is a major complication of allogeneic bone marrow and peripheral blood stem
cell transplantation. The main risk factors include previous aGVHD, advanced recipient
age, female donor to male recipient, transplant in patient with chronic myelogenous
leukemia, previous splenectomy, second allogeneic transplant and a high degree of HLA
mismatching.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> Chronic GVHD has
an important impact on the survival and quality of life of transplanted patients. The
skin is the most commonly involved organ, followed by the oral mucosa, liver, eye and GI
tract, but virtually all organs or systems may be involved.<sup><xref ref-type="bibr" rid="r03">3</xref>-<xref ref-type="bibr" rid="r06">6</xref></sup> Skin lesions in
cGVHD are initially subtle with xerosis, follicular hyperkeratosis or with a
pityriasiform, psoriasiform and eczematous aspect. Later on, more classic lesions of
lichenoid or sclerodermoid pattern appear.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup> Sclerotic skin changes
are a prominent feature and a major source of morbidity. Dermal fibrosis may involve all
layers of the skin with loss of subcutaneous tissue and may include the fascia and
tendon.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Our patient presents
diffuse spotted hyperpigmentation and hypopigmentation associated with multiple
lichenoid and small atrophic, scaly and hypopigmented plaques with histopathological
presentation of atrophic epidermis and discrete lichenoid pattern.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Buccal lesions manifest as gingivitis,
mucositis, xerostomia and ulcers as observed. Involvement of oral mucosa is frequent and
may be very relevant affecting the health and quality of life of patients.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
Despite the expressive mucocutaneous and adnexal involvement, no evidence of systemic
disease has been detected in this particular patient so far, although this possibility
cannot be ruled out during the patient's follow-up .</p>
      <p>Systemic steroids are the appropriate first-line treatment for both acute and chronic
GVHD, but if the patient is steroid refractory an alternative is the association of
extracorporeal photopheresis, prednisone and sirolimus, or prednisone, sirolimus plus
calcineurin inhibitors.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r07">7</xref>-<xref ref-type="bibr" rid="r09">9</xref></sup>
Localized, cutaneous GVHD may respond well to topical steroids or, alternatively, to
tacrolimus and pimecrolimus.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> Although
hematopoietic cell transplanted patients are counseled to avoid ultraviolet radiation
due to possible GVHD flare or increased risk of skin cancer, psoralens plus ultraviolet
A light (PUVA) or narrow band-ultraviolet B phototherapy are the choice for the
treatment of sclerotic cGVHD lesions.<sup><xref ref-type="bibr" rid="r07">7</xref>-<xref ref-type="bibr" rid="r09">9</xref></sup> It is also important to have in mind that
these patients have increased risk of secondary malignancies of the skin or mucosa
including squamous cell carcinoma and melanoma, therefore dermatological screenings are
recommended throughout life.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn03" fn-type="other">
        <p>* Work performed at the Department of Dermatology and Radiotherapy. Botucatu Medical
School, S&#xE3;o Paulo State University "J&#xFA;lio de Mesquita Filho"
(FMB-UNESP) - Botucatu (SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrara</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Holler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Graft-versus-host disease</article-title>
          <source>Lancet</source>
          <year>2009</year>
          <volume>373</volume>
          <fpage>1550</fpage>
          <lpage>1561</lpage>
          <pub-id pub-id-type="pmid">19282026</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hymes</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Alousi</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cowen</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Graft-versus-host disease. Part I. Pathogenesis and clinical
manifestation of graft-versus-host disease</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2012</year>
          <volume>66</volume>
          <fpage>515</fpage>
          <fpage>e1</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">22421123</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flowers</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Inamoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kiem</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Petersdorf</surname>
              <given-names>EW</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Comparative analysis of risk factors for acute graft-versus-host
disease and for chronic graft-versus-host disease according to National Institute
of Health consensus criteria</article-title>
          <source>Blood</source>
          <year>2011</year>
          <volume>117</volume>
          <fpage>3214</fpage>
          <lpage>3219</lpage>
          <pub-id pub-id-type="pmid">21263156</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filipovich</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Weisdorf</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pavletic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Socie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wingard</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>National Institutes of Health consensus development project on
criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis
and staging working group report</article-title>
          <source>Biol Blood Marrow Transplant</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>945</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="pmid">16338616</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hymes</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Champlin</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Couriel</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous manifestations of chronic graft-versus-host
disease</article-title>
          <source>Biol Blood Marrow Transplant</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>1101</fpage>
          <lpage>1113</lpage>
          <pub-id pub-id-type="pmid">17085303</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Bouzas</surname>
              <given-names>LFS</given-names>
            </name>
            <name>
              <surname>Filgueira</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Tegumentary manifestations of graft-versushost disease in bone marrow
transplantation recipients</article-title>
          <source>An Bras Dermatol</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>69</fpage>
          <lpage>80</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hymes</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Alousi</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cowen</surname>
              <given-names> EW</given-names>
            </name>
          </person-group>
          <article-title>Graft-versus-host disease: part II. Management of cutaneous
graft-versus-host disease</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2012</year>
          <volume>66</volume>
          <fpage>535</fpage>
          <fpage>e1</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">22421124</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruandmann-Kollmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ludwig</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boehncke</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Hoelzer</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Narrowband UV-B phototherapy in the treatment of cutaneous graft
versus host disease</article-title>
          <source>Transplantation</source>
          <year>2002</year>
          <volume>74</volume>
          <fpage>1631</fpage>
          <lpage>1634</lpage>
          <pub-id pub-id-type="pmid">12490799</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weitzing</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sticherling</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hegenbart</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Niederwieser</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Al-Ali</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>Medium dose long-wavelenght ultraviolet A (UVA-1) photherapy for the
treatment of acute and chronic graft-versus-host disease</article-title>
          <source>Bone Marrow Transplant</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>515</fpage>
          <lpage>519</lpage>
          <pub-id pub-id-type="pmid">15665847</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leisenring</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Flowers</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Deeg</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Nonmelanoma skin and mucosal cancers after hematopoietic cell
transplantation</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>1119</fpage>
          <lpage>1126</lpage>
          <pub-id pub-id-type="pmid">16461782</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f02" orientation="portrait" position="float">
      <label>FIGURE 2</label>
      <caption>
        <p>Graft-versus-host disease: scalp with alopecia and spotted hyper and hypopigmented
skin plus lichenoid lesions</p>
      </caption>
      <graphic xlink:href="abd-88-05-0799-g02"/>
    </fig>
    <fig id="f03" orientation="portrait" position="float">
      <label>FIGURE 3</label>
      <caption>
        <p>Graft-versus-host disease: lichenoid lesions, edema and erythema on the hands with
associated onychodistrophia</p>
      </caption>
      <graphic xlink:href="abd-88-05-0799-g03"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
